Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'p53 and mdm2 proteins interaction inhibitor racemic'

Search results for: 'p53 and mdm2 proteins interaction inhibitor racemic'

Items 51-60 of 101

Page
per page
  1. NVP-BSK805 2HCl
    A4148 NVP-BSK805 2HCl
    Target: JAK
    Summary: JAK2 inhibitor
      ≥30.8 mg/mL
  2. AZD3759
    B5962 AZD3759
    Summary: EGFR inhibitor，oral active
      ≥23 mg/mL
  3. CX-6258
    A3337 CX-6258
    Summary: Pan-Pim kinases Inhibitor
      insoluble in EtOH; ≥11.15 mg/mL
  4. Lapatinib
    A8218 Lapatinib
     2 Citation
    Target: ErbB
    Summary: EGFR/HER2 inhibitor,potent,selective and reversible
      ≥29.05 mg/mL
  5. Tofacitinib (CP-690550) Citrate
    A4135 Tofacitinib (CP-690550) Citrate
     2 Citation
    Target: JAK
    Summary: Potent JAK inhibitor
      ≥25.22 mg/mL
  6. Lapatinib Ditosylate
    A3967 Lapatinib Ditosylate
    Target: EGFR|ErbB-2
    Summary: EGFR/HER2 inhibitor,potent and selective
      ≥24.3 mg/mL
  7. Baricitinib phosphate
    A3222 Baricitinib phosphate
    Summary: JAK1/JAK2 inhibitor
      insoluble in EtOH; insoluble in H2O; ≥172.6 mg/mL
  8. ZM 449829
    A4517 ZM 449829
    Summary: JAK3 inhibitor
      insoluble in H2O; insoluble in EtOH; ≥8.2 mg/mL
  9. TCS-PIM-1-4a
    B4764 TCS-PIM-1-4a
    Summary: Pim inhibitor
  10. S-Ruxolitinib (INCB018424)
    A4149 S-Ruxolitinib (INCB018424)
    Target: JAK
    Summary: JAK1/2 inhibitor,potent and selective
      Soluble in DMSO

Items 51-60 of 101

Page
per page